PKM and hepatocellular carcinoma: LncRNA MEG3 promotes the expression and maturation of miR122 and inhibits the expression of PKM2 by targeting through miR122, which reduces the expression of liver cancer cells cell-cycle protein D1 and C-Myc, and inhibits the proliferation and differentiation of HCC cells [61].